Literature DB >> 4536682

Plasma prekallikrein: isolation, characterization, and mechanism of activation.

K D Wuepper, C G Cochrane.   

Abstract

The precursor of the kinin-forming enzyme, prekallikrein, was isolated from rabbit plasma protected from activation during preparatory procedures. Prekallikrein was shown to be a 4.5S gamma(1)-glycoprotein with an isoelectric point of 5.9 and a mol wt of 99,900. The proenzyme was activated at neutral pH by an enzyme from rabbit or human plasma we have termed prekallikrein activator (PKA) or by trypsin. Prekallikrein was activated by PKA by a process of enzymatic scission. This resulted in the appearance of two fragments; the larger of these possessed kallikrein activity.

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 4536682      PMCID: PMC2139124          DOI: 10.1084/jem.135.1.1

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  18 in total

1.  A method of trace iodination of proteins for immunologic studies.

Authors:  P J McConahey; F J Dixon
Journal:  Int Arch Allergy Appl Immunol       Date:  1966

2.  [Purification and some characteristics of a kallikrein from swine serum].

Authors:  E Habermann; W Klett
Journal:  Biochem Z       Date:  1966-09-08

3.  Molecular weight estimation of polypeptide chains by electrophoresis in SDS-polyacrylamide gels.

Authors:  A L Shapiro; E Viñuela; J V Maizel
Journal:  Biochem Biophys Res Commun       Date:  1967-09-07       Impact factor: 3.575

4.  Partial purification of bovine plasma kallikreinogen, its activation by the Hageman factor.

Authors:  S Nagasawa; H Takahashi; M Koida; T Suzuki; J G Schoenmakers
Journal:  Biochem Biophys Res Commun       Date:  1968-08-21       Impact factor: 3.575

5.  A pre-albumin activator of prekallikrein.

Authors:  A P Kaplan; K F Austen
Journal:  J Immunol       Date:  1970-10       Impact factor: 5.422

6.  The reliability of molecular weight determinations by dodecyl sulfate-polyacrylamide gel electrophoresis.

Authors:  K Weber; M Osborn
Journal:  J Biol Chem       Date:  1969-08-25       Impact factor: 5.157

7.  The gel-filtration behaviour of proteins related to their molecular weights over a wide range.

Authors:  P Andrews
Journal:  Biochem J       Date:  1965-09       Impact factor: 3.857

8.  Inhibition of Hageman factor activation.

Authors:  H L Nossel; H Rubin; M Drillings; R Hsieh
Journal:  J Clin Invest       Date:  1968-05       Impact factor: 14.808

9.  Studies on the prekallikrein (kallikreinogen)--kallikrein enzyme system of human plasma. I. Isolation and purification of plasma kallikreins.

Authors:  R W Colman; L Mattler; S Sherry
Journal:  J Clin Invest       Date:  1969-01       Impact factor: 14.808

10.  A prealbumin activator of prekallikrein. II. Derivation of activators of prekallikrein from active Hageman factor by digestion with plasmin.

Authors:  A P Kaplan; K F Austen
Journal:  J Exp Med       Date:  1971-04-01       Impact factor: 14.307

View more
  23 in total

1.  Influence of a novel inhibitor (UM8190) of prolylcarboxypeptidase (PRCP) on appetite and thrombosis.

Authors:  F M Rabey; R S V S Gadepalli; S Diano; Q Cheng; T Tabrizian; D Gailani; J M Rimoldi; Z Shariat-Madar
Journal:  Curr Med Chem       Date:  2012       Impact factor: 4.530

Review 2.  FXII.

Authors:  G Fuhrer; M J Gallimore; W Heller; H E Hoffmeister
Journal:  Blut       Date:  1990-11

3.  A kallikrein-targeting RNA aptamer inhibits the intrinsic pathway of coagulation and reduces bradykinin release.

Authors:  K-A Steen Burrell; J Layzer; B A Sullenger
Journal:  J Thromb Haemost       Date:  2017-08-02       Impact factor: 5.824

4.  The relationship of structure and function in human Hageman factor. The association of enzymatic and binding activities with separate regions of the molecule.

Authors:  S D Revak; C G Cochrane
Journal:  J Clin Invest       Date:  1976-04       Impact factor: 14.808

5.  Structural changes accompanying enzymatic activation of human Hageman factor.

Authors:  S D Revak; C G Cochrane; A R Johnston; T E Hugli
Journal:  J Clin Invest       Date:  1974-09       Impact factor: 14.808

6.  The interaction of Hageman factor and immune complexes.

Authors:  C G Cochrane; K D Wuepper; B S Aiken; S D Revak; H L Spiegelberg
Journal:  J Clin Invest       Date:  1972-10       Impact factor: 14.808

7.  The glomerular polyanion (GPA) of the rat kidney. III. Further characterization of a vaso-active serum factor which reduces GPA.

Authors:  W W Bakker; G Roskam; M J Hardonk; J T Vos; E Bleumink
Journal:  Br J Exp Pathol       Date:  1985-02

8.  Rabbit prekallikrein. Purification, biochemical characterization, and mechanism of activation.

Authors:  R J Ulevitch; C G Cochrane; A R Johnston
Journal:  Inflammation       Date:  1980-03       Impact factor: 4.092

9.  Human plasma kallikrein. A rapid purification method with high yield.

Authors:  H Nagase; A J Barrett
Journal:  Biochem J       Date:  1981-01-01       Impact factor: 3.857

10.  Inhibitors of kallikrein in human plasma.

Authors:  D J McConnell
Journal:  J Clin Invest       Date:  1972-07       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.